跳至主要内容
临床试验/ISRCTN15022302
ISRCTN15022302已完成Unknown

Effectiveness of a cannabidiol supplement on sleep and mood in adults with nonclinical insomnia: a randomized double-blind placebo-controlled crossover pilot trial

Sanna, LLC0 个研究点目标入组 20 人开始时间: 2024年5月20日最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Adults (between the ages of 18 to 75 years) with nonclinical insomnia symptoms (as determined by the Insomnia Severity Index)

排除标准

  • 1. Severe insomnia (based on the Insomnia Severity Index (ISI = 22) or nonclinical insomnia (ISI < 8)
  • 2. History of a diagnosed disorder affecting sleep quality
  • 3. Reported events that could cause severe stress within 2 weeks of baseline
  • 4. Use of medication that could influence sleep patterns within 1 month of the trial
  • 5. Use of hormone therapy
  • 6. Binge alcohol consumption
  • 7. Smoking
  • 8. High caffeine intake
  • 9. Work schedule that causes irregular sleep patterns
  • 10. History of travel to a different time zone within 1 month of the study
  • 11. Low or high body mass index (BMI = 18 kg/m2 or = 35 kg/m2)
  • 12. Pregnant, trying to conceive, or breastfeeding
  • 13. Taking sleep supplements or medication
  • 14. Unwilling to abstain from other cannabis/hemp product use for two weeks prior to and during the trial
  • 15. Individuals deemed unable to complete the protocol as designed

研究者

发起方
Sanna, LLC

相似试验